Sign in
4

Changes in Ownership

Inspire Medical Systems, Inc. Filed Acc 0001104659-24-114302

Chief Technology Officer sold 8,703 shares at an average $193.47 ($1,683,731)

  • Chief Technology Officer acquired 8,703 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Rondoni John Chief Technology Officer 2024-11-01 Option exercise 10b5-1 +5,802 $71.00 $411,942 17,150 D: show line 1 in the form
Rondoni John Chief Technology Officer 2024-11-01 Option exercise 10b5-1 +2,901 $42.15 $122,277 20,051 D: show line 2 in the form
Rondoni John Chief Technology Officer 2024-11-01 Sale 10b5-1 −5,777 $192.93 $1,114,557 14,274 D: show line 3 in the form
Rondoni John Chief Technology Officer 2024-11-01 Sale 10b5-1 −1,580 $193.92 $306,394 12,694 D: show line 4 in the form
Rondoni John Chief Technology Officer 2024-11-01 Sale 10b5-1 −1,013 $194.84 $197,373 11,681 D: show line 5 in the form
Rondoni John Chief Technology Officer 2024-11-01 Sale 10b5-1 −333 $196.42 $65,408 11,348 D: show line 6 in the form
Open-market sales · 8,703 sh · avg $193.47 · $1,683,731

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Rondoni John Chief Technology Officer 2024-11-01 Option exercise · Employee Stock Option (Right to Buy) 10b5-1 −5,802 1,448 D: show line 7 in the form
Rondoni John Chief Technology Officer 2024-11-01 Option exercise · Employee Stock Option (Right to Buy) 10b5-1 −2,901 9,197 D: show line 8 in the form
Loading xslF345X05/tm2427544-1_4seq1.xml…